LKFT
23.858 EUR
-0.25%
Today
-1.86%
1D
Market is closed
Sun
Closed
Mon
10:01 AM ~ 6:30 PM
Tue
10:01 AM ~ 6:30 PM
Wed
10:01 AM ~ 6:30 PM
Thu
10:01 AM ~ 6:30 PM
Fri
10:01 AM ~ 6:30 PM
Sat
Closed
Information
Name
Lakefront Biotherapeutics Leveraged ( NL )
Currency
EUR
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0137%
Overnight Fees Sell
-0.0030%
Market Cap
1.55B
Avg Daily Volume
81.35K
52 Week High
32.74 EUR
52 Week Low
22.92 EUR
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01370% | $(0.137) |
| SELLS | -0.00300% | $(0.030) |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that is in phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Top News
Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update
tradingview.com
2w ago
Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026
tradingview.com
3w ago
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
tradingview.com
1mo ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
